Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is Safe and Credible Online Health Resource
August 01 2018 - 8:00AM
InvestorsHub NewsWire
Progressive Care
Earns Coveted
LegitScript Certification
Verifying PharmCo Pharmacy
is a Safe and Credible
Online Health Resource
MIAMI, FL -- August
1, 2018 -- InvestorsHub NewsWire
-- Progressive Care Inc. (OTCQB: RXMD),
a personalized
healthcare
services and technology company,
today
announced that its
subsidiary,
PharmCo, LLC,
has
received
certification
approval from
LegitScript to
provide verification
that it
is operating
in compliance with applicable laws and regulation
set
forth to be a
safe
and credible online health resource.
The
LegitScript
verification
allows the company to begin
marketing
and
advertising
PharmCo
products and services online.
In addition, Progressive Care will
be able to
move forward with further
efforts on its
opioid
alternative treatment program launched
earlier this year.
Through
this
verification,
patients
and physicians will have
the opportunity to
learn more about PharmCo's
alternative
pain management therapies and
how to best integrate these treatments into a medication
regimen.
"Progressive
Care continues to look for
new
ways to expand
our market
share and network
of patients, physicians, and providers. This
new certification from LegitScript
not
only showcases
the
credibility of the PharmCo
Pharmacy,
but
also enables
us
to
continue
sharing
our
message with
a larger audience,"
said S. Parikh Mars, CEO of Progressive Care Inc.
"We
are also
excited
about the new market
opportunities
this verification presents
and believe
this
additional level of credibility will have a significant impact on
company sales moving forward."
Progressive
Care
began
the verification process with LegitScript
in
May 2018 and received
final approval
on
July 31, 2018.
Completion
of the
LegitScript
certification
process is
one of Progressive Care's many efforts to
expand and educate its
network. The company recently launched
an
opioid alternative treatment
campaign in an
effort to combat the nationwide opioid epidemic. The company also
launched DischargeRx,
a
new
proprietary patient engagement program designed to ensure that
hospital patients are receiving the best transitional care while
preserving vital hospital resources.
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB:
RXMD),
through its PharmCo, LLC, is a South Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of
tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription
medications to long term care facilities, and health practice risk
management.
Cautionary Statement Regarding Forward Looking
Statements
Statements contained herein that are not based upon current
or historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target," "intend" and "expect" and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject
to a number of risks, uncertainties, and other
factors that could cause the Company's actual results, performance,
prospects, and opportunities to differ materially from those
expressed in, or implied by, these forward-looking
statements.
Public Relations Contact:
Tory Patterson,
CMW Media
Tory@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Jul 2023 to Jul 2024